Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 11 | 2022 | 103 | 4.700 |
Why?
|
| Stroke | 12 | 2019 | 286 | 3.120 |
Why?
|
| Brain Ischemia | 7 | 2020 | 184 | 2.550 |
Why?
|
| Hawaii | 24 | 2019 | 1929 | 1.640 |
Why?
|
| Brain Injuries | 4 | 2014 | 121 | 1.510 |
Why?
|
| Hospitalization | 5 | 2024 | 388 | 1.360 |
Why?
|
| Retrospective Studies | 19 | 2024 | 2026 | 1.230 |
Why?
|
| Pre-Eclampsia | 2 | 2019 | 61 | 1.170 |
Why?
|
| Patient Readmission | 2 | 2018 | 73 | 1.120 |
Why?
|
| Female | 38 | 2020 | 20969 | 0.990 |
Why?
|
| Middle Aged | 29 | 2020 | 10129 | 0.980 |
Why?
|
| Aged | 23 | 2023 | 6741 | 0.930 |
Why?
|
| Longevity | 2 | 2022 | 147 | 0.930 |
Why?
|
| Humans | 49 | 2024 | 37093 | 0.890 |
Why?
|
| Male | 33 | 2023 | 20025 | 0.870 |
Why?
|
| Decompressive Craniectomy | 2 | 2011 | 4 | 0.770 |
Why?
|
| Aged, 80 and over | 13 | 2023 | 2379 | 0.770 |
Why?
|
| Hypertension | 4 | 2023 | 796 | 0.740 |
Why?
|
| Adult | 21 | 2019 | 11712 | 0.740 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2020 | 4 | 0.730 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 70 | 0.720 |
Why?
|
| Patient Discharge | 4 | 2016 | 93 | 0.690 |
Why?
|
| Hospital Costs | 1 | 2019 | 24 | 0.690 |
Why?
|
| Embolism, Paradoxical | 1 | 2019 | 3 | 0.680 |
Why?
|
| Foramen Ovale, Patent | 1 | 2019 | 5 | 0.680 |
Why?
|
| Health Status Disparities | 3 | 2024 | 642 | 0.680 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 13 | 0.670 |
Why?
|
| Prevalence | 4 | 2017 | 1455 | 0.670 |
Why?
|
| Homeostasis | 2 | 2011 | 188 | 0.660 |
Why?
|
| Intracranial Hemorrhages | 2 | 2017 | 26 | 0.640 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 39 | 0.630 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 494 | 0.610 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 10 | 0.600 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 1 | 2016 | 2 | 0.570 |
Why?
|
| Quadriplegia | 1 | 2016 | 5 | 0.570 |
Why?
|
| Patient Transfer | 2 | 2019 | 23 | 0.550 |
Why?
|
| Social Work Department, Hospital | 1 | 2015 | 2 | 0.530 |
Why?
|
| Intracranial Hypertension | 2 | 2012 | 5 | 0.520 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2012 | 9 | 0.520 |
Why?
|
| Air Ambulances | 1 | 2015 | 5 | 0.510 |
Why?
|
| Blood Coagulation Factors | 1 | 2014 | 6 | 0.510 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 10 | 0.510 |
Why?
|
| Withholding Treatment | 1 | 2015 | 30 | 0.510 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 26 | 0.500 |
Why?
|
| Needs Assessment | 2 | 2015 | 170 | 0.490 |
Why?
|
| Length of Stay | 2 | 2016 | 185 | 0.490 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 146 | 0.480 |
Why?
|
| Warfarin | 1 | 2014 | 64 | 0.470 |
Why?
|
| Anticoagulants | 1 | 2014 | 102 | 0.470 |
Why?
|
| Resuscitation Orders | 1 | 2013 | 8 | 0.460 |
Why?
|
| Family | 1 | 2015 | 173 | 0.460 |
Why?
|
| Risk Factors | 8 | 2023 | 3562 | 0.460 |
Why?
|
| Disabled Persons | 1 | 2014 | 65 | 0.450 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 215 | 0.450 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 174 | 0.430 |
Why?
|
| Methamphetamine | 1 | 2015 | 159 | 0.430 |
Why?
|
| Paresis | 2 | 2011 | 8 | 0.420 |
Why?
|
| Sex Factors | 4 | 2018 | 898 | 0.420 |
Why?
|
| Young Adult | 8 | 2019 | 4268 | 0.400 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2011 | 2 | 0.400 |
Why?
|
| Body Temperature | 1 | 2011 | 36 | 0.390 |
Why?
|
| Attitude to Health | 1 | 2014 | 325 | 0.390 |
Why?
|
| Vasoconstriction | 1 | 2011 | 42 | 0.390 |
Why?
|
| Vasopressins | 1 | 2011 | 13 | 0.390 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 9 | 0.390 |
Why?
|
| Functional Laterality | 1 | 2011 | 80 | 0.390 |
Why?
|
| Organ Transplantation | 1 | 2011 | 18 | 0.390 |
Why?
|
| Parkinson Disease | 2 | 2024 | 178 | 0.380 |
Why?
|
| Registries | 1 | 2013 | 335 | 0.380 |
Why?
|
| Pregnancy | 4 | 2019 | 1549 | 0.370 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2016 | 22 | 0.360 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 610 | 0.350 |
Why?
|
| Obesity | 2 | 2014 | 1067 | 0.350 |
Why?
|
| Posterior Cerebral Artery | 1 | 2009 | 3 | 0.340 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 485 | 0.340 |
Why?
|
| Age Factors | 4 | 2016 | 1033 | 0.330 |
Why?
|
| Visual Cortex | 1 | 2009 | 60 | 0.330 |
Why?
|
| Meninges | 1 | 2008 | 6 | 0.320 |
Why?
|
| Prealbumin | 1 | 2008 | 5 | 0.320 |
Why?
|
| Eclampsia | 1 | 2008 | 9 | 0.320 |
Why?
|
| Threonine | 1 | 2008 | 25 | 0.320 |
Why?
|
| Caregivers | 3 | 2015 | 182 | 0.320 |
Why?
|
| Amyloidosis | 1 | 2008 | 33 | 0.320 |
Why?
|
| Proline | 1 | 2008 | 43 | 0.310 |
Why?
|
| Blood Pressure | 4 | 2011 | 646 | 0.280 |
Why?
|
| Odds Ratio | 3 | 2018 | 534 | 0.270 |
Why?
|
| Fibrinolytic Agents | 2 | 2016 | 25 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 214 | 0.260 |
Why?
|
| United States | 4 | 2019 | 4223 | 0.250 |
Why?
|
| Qualitative Research | 3 | 2015 | 446 | 0.240 |
Why?
|
| Mutation | 1 | 2008 | 1095 | 0.230 |
Why?
|
| Genotype | 2 | 2023 | 730 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 481 | 0.220 |
Why?
|
| Prospective Studies | 3 | 2024 | 1378 | 0.220 |
Why?
|
| Dementia, Vascular | 1 | 2023 | 36 | 0.220 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 78 | 0.200 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2011 | 10 | 0.200 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 129 | 0.200 |
Why?
|
| Rib Fractures | 1 | 2020 | 4 | 0.190 |
Why?
|
| Thoracic Injuries | 1 | 2020 | 11 | 0.190 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 12 | 0.190 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2020 | 29 | 0.190 |
Why?
|
| Middle Cerebral Artery | 2 | 2011 | 16 | 0.190 |
Why?
|
| Perfusion Imaging | 1 | 2020 | 2 | 0.180 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 2721 | 0.180 |
Why?
|
| Brain | 3 | 2012 | 1346 | 0.180 |
Why?
|
| Thrombolytic Therapy | 2 | 2016 | 17 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2019 | 291 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 767 | 0.160 |
Why?
|
| Time Factors | 3 | 2020 | 1742 | 0.150 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 63 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2016 | 88 | 0.150 |
Why?
|
| Skull Fractures | 1 | 2017 | 4 | 0.150 |
Why?
|
| Drug Costs | 1 | 2017 | 28 | 0.150 |
Why?
|
| Cerebral Revascularization | 2 | 2019 | 5 | 0.140 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 40 | 0.140 |
Why?
|
| Survivors | 2 | 2014 | 136 | 0.140 |
Why?
|
| Age of Onset | 1 | 2016 | 100 | 0.140 |
Why?
|
| Glasgow Coma Scale | 2 | 2013 | 18 | 0.140 |
Why?
|
| Hospital Mortality | 1 | 2018 | 187 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 77 | 0.140 |
Why?
|
| Comorbidity | 2 | 2018 | 623 | 0.140 |
Why?
|
| After-Hours Care | 1 | 2016 | 5 | 0.140 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 12 | 0.140 |
Why?
|
| Nurse Practitioners | 1 | 2016 | 14 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2016 | 1369 | 0.140 |
Why?
|
| Minority Health | 1 | 2016 | 88 | 0.130 |
Why?
|
| Telemedicine | 1 | 2019 | 182 | 0.130 |
Why?
|
| Budgets | 1 | 2015 | 9 | 0.130 |
Why?
|
| Economics, Hospital | 1 | 2015 | 10 | 0.130 |
Why?
|
| Intracranial Pressure | 2 | 2012 | 7 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 905 | 0.130 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 48 | 0.130 |
Why?
|
| Transportation of Patients | 1 | 2014 | 14 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2014 | 64 | 0.120 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 57 | 0.120 |
Why?
|
| Pacific Islands | 1 | 2015 | 119 | 0.120 |
Why?
|
| Coma | 1 | 2014 | 4 | 0.120 |
Why?
|
| Disease Progression | 1 | 2017 | 601 | 0.120 |
Why?
|
| Risk | 1 | 2014 | 267 | 0.120 |
Why?
|
| Heart Arrest | 1 | 2014 | 35 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2017 | 753 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2014 | 126 | 0.120 |
Why?
|
| Glasgow Outcome Scale | 1 | 2013 | 6 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 111 | 0.110 |
Why?
|
| Radiography | 1 | 2012 | 72 | 0.110 |
Why?
|
| Fluid Therapy | 1 | 2012 | 28 | 0.110 |
Why?
|
| Social Support | 1 | 2015 | 394 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 583 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1039 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2014 | 322 | 0.100 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 40 | 0.100 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 61 | 0.100 |
Why?
|
| Diuretics, Osmotic | 1 | 2011 | 5 | 0.100 |
Why?
|
| Mannitol | 1 | 2011 | 11 | 0.100 |
Why?
|
| Brain Death | 1 | 2011 | 9 | 0.100 |
Why?
|
| Fever | 1 | 2011 | 57 | 0.100 |
Why?
|
| Models, Biological | 1 | 2014 | 677 | 0.100 |
Why?
|
| Hypotension | 1 | 2011 | 23 | 0.100 |
Why?
|
| Coronary Angiography | 1 | 2011 | 90 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 41 | 0.100 |
Why?
|
| Heart Rupture | 1 | 2010 | 2 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2011 | 91 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2014 | 854 | 0.090 |
Why?
|
| Nervous System | 1 | 2010 | 29 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 61 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2010 | 61 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2012 | 86 | 0.090 |
Why?
|
| Quality of Life | 1 | 2014 | 481 | 0.090 |
Why?
|
| Vascular Resistance | 1 | 2009 | 34 | 0.080 |
Why?
|
| Vision, Ocular | 1 | 2009 | 41 | 0.080 |
Why?
|
| Vasodilation | 1 | 2009 | 65 | 0.080 |
Why?
|
| Infant | 1 | 2012 | 1046 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2008 | 64 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2009 | 156 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 93 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1130 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2012 | 1418 | 0.080 |
Why?
|
| Prognosis | 3 | 2017 | 739 | 0.080 |
Why?
|
| Heart Rate | 1 | 2009 | 253 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 664 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 404 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2016 | 47 | 0.060 |
Why?
|
| Adolescent | 1 | 2014 | 5363 | 0.060 |
Why?
|
| Prescriptions | 1 | 2021 | 18 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2020 | 79 | 0.050 |
Why?
|
| Incidence | 1 | 2023 | 922 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 885 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2019 | 117 | 0.040 |
Why?
|
| Aging | 1 | 2022 | 664 | 0.040 |
Why?
|
| Lovastatin | 1 | 2017 | 10 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2017 | 84 | 0.040 |
Why?
|
| Simvastatin | 1 | 2017 | 29 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 191 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 144 | 0.030 |
Why?
|
| Medicare | 1 | 2017 | 195 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2014 | 23 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 339 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2014 | 381 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 400 | 0.030 |
Why?
|
| Neurology | 1 | 2012 | 12 | 0.030 |
Why?
|
| Cardiology | 1 | 2012 | 17 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2012 | 16 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 39 | 0.030 |
Why?
|
| Seizures | 1 | 2012 | 68 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 56 | 0.020 |
Why?
|
| Forecasting | 1 | 2012 | 128 | 0.020 |
Why?
|
| Calibration | 1 | 2011 | 56 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 77 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 275 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 268 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 142 | 0.020 |
Why?
|
| Myocardium | 1 | 2010 | 235 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1492 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 15081 | 0.020 |
Why?
|